Praxsyn Corporation Announces New Financial Controller

Media/Investor Contact:  

IR@praxsyn.com

949-777-6112 ext 101

Las Vegas, Nevada, April 27, 2017 -- Praxsyn Corporation (OTCQB: PXYN) is pleased to announce the promotion of Stephanie Kaitz to the position of Financial Controller.

Praxsyn’s Chief Executive Officer, Greg Sundem, commented, “Stephanie has always been a person who can get things done in the office. Stephanie brings a strong cash management skill set to her new role, and is working closely with our auditing firm to finalize our financial reporting and will keep our filings current in the future. I am thrilled to have her on our team and that she made the move to Nevada as we continue to work on efficiencies and a broader sales base. Stephanie will be a key asset in our continued expansion”.

Kimberly Brooks, Praxsyn’s Secretary and General Counsel, commented, “Stephanie has been an integral part of the company for the past three years and has been an amazing employee.  She has worked her way up the ladder starting in Data Entry all the way up to Director of Operations for both subsidiaries.  It is an honor and a joy to work with her in the company’s new pharmacy endeavor in Las Vegas”.

Stephanie has over 15 years of accounting experience, including acting as an accounting manager at a real estate firm and credit counseling firm.  Most recently, Stephanie worked for the company as the Director of Operations for both Mesa Pharmacy, Inc. and Nevada Health Rx, Inc.  Stephanie earned a Bachelor’s of Science degree in Business Administration and a Master’s of Arts degree in Management from the University of Redlands in Redlands, California.

Justin Cary is no longer acting in his position as Chief Financial Officer of Praxsyn or any of its subsidiaries, and Stephanie shall take over all of his job duties, including, but not limited to, oversight of the financial reporting, accounts payable and receivable, and cash management.

About Praxsyn Corporation

Headquartered in Las Vegas, Nevada, Praxsyn Corporation is a holding company that finds solutions to fit the needs and goals of medical professionals and their patients.  Both Nevada Health Rx and Mesa Pharmacy work to realize the vision of medical professionals to improve the lives of their patients.  Additional company information can be found at www.praxsyn.com.

Forward-Looking Statements

Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to statements in this press release regarding hiring a new financial controller, and thus accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports as have been filed with the Securities and Exchange Commission.

 

                                                                      ###

Praxsyn Corporation Acquires Nevada Pharmacy

Media/Investor Contact:  

IR@praxsyn.com

949-777-6112 ext 101

LAS VEGAS, Nevada, April 18, 2017 -- Praxsyn Corporation (OTCQB: PXYN) is pleased to announce that it has purchased through a newly formed subsidiary, Nevada Health Rx, Inc., the pharmacy license and all of the assets of Meds Direct Rx, a pharmacy located in Las Vegas, Nevada.  The new pharmacy is about 8,000+ square feet of pharmacy and warehouse space, and includes a large loading dock and a secured yard to hold delivery vehicles.   

The total purchase price for the acquisition of the pharmacy was $120,000, $50,000 was paid at the closing date and the residual $70,000 is to be paid pursuant to a promissory note over six months at 6.5% per annum.  In connection with this transaction, the company has received financing commitments through promissory notes and internal resources to fund the purchase price, transaction-related costs, and the ongoing business operations and capital needs of the new pharmacy until it is in a positive cash flow position.  One of the material terms of the promissory notes, as insisted by the investor, is the continued service of the company’s Chief Executive Officer and Chairman of the Board, Greg Sundem.

Greg Sundem commented that “This acquisition will allow us to sell a broader mix of products from a much larger facility than we have had in the past.  Our focus is on filling prescriptions that have a 30 day pay cycle instead of the multiple year collection cycles that we have experienced in the past.  Our focus, as always, is on customer service to our patients, their doctors, the surgery centers and hospitals that will serve our patients and our VIP customers.  I am excited that through this acquisition we are executing the plan that we have had for several years, but have been unable to execute, but we are there now, growing and expanding in a much more financially stable plan.  Additionally, I can now tell you that we are working as expeditiously as possible to finalize 2015 and 2016 financial reporting.  We are pushing hard to get caught up on our financial reporting, including the first quarter of 2017.”

We will be releasing further updates and financial reporting as soon as it becomes available.

About Praxsyn Corporation

Headquartered in Las Vegas, Nevada, Praxsyn Corporation is a holding company that finds solutions to fit the needs and goals of medical professionals and their patients.  Nevada Health Rx and Mesa Pharmacy, work to realize the vision of medical professionals to improve the lives of their patients.  Additional company information can be found at www.praxsyn.com.

 

Forward-Looking Statements

Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to statements in this press release regarding the acquisition of the Nevada pharmacy, Nevada Health Rx, and thus accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports as have been filed with the Securities and Exchange Commission.

 

                                                                             ###

Praxsyn’s Appointment of Vstock Transfer as New Transfer Agent

Media/Investor Contact:  

IR@praxsyn.com

949-777-6112 ext 101

Las Vegas, Nevada, March 15, 2017 -- Praxsyn Corporation (OTCQB: PXYN) is pleased to announce the appointment of VStock Transfer, LLC as the company’s new transfer agent.  VStock Transfer, as the company’s official registrar of all stock records, shall be responsible for all certificate issuances, lost certificate replacements, certificate transfers, non-certificated book-entry transactions, restricted stock transfers, and digitized recordkeeping for shareholder communications and documentation.

To contact VStock Transfer, Praxsyn’s shareholders may call (212) 828-8436 or email l-z@vstocktransfer.com.

About Praxsyn Corporation

Headquartered in Las Vegas, Nevada, Praxsyn Corporation is a holding company that finds solutions to fit the needs and goals of medical professionals and their patients.  Mesa Pharmacy, located in Irvine, California works to realize the vision of medical professionals to improve the lives of their patients. Mesa Pharmacy continues its operations and services in Irvine, California to provide patients with pharmaceutical treatments as prescribed by their doctors.  Additional company information can be found at www.praxsyn.com.

Forward-Looking Statements

Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to statements in this press release regarding Praxsyn Corporation’s new transfer agent, VStock Transfer, LLC, accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports as have been filed with the Securities and Exchange Commission.

 

                                                                              ###

Praxsyn’s Move of Corporate Headquarters to Nevada

Media/Investor Contact:  

IR@praxsyn.com

949-777-6112 ext 101

IRVINE, Calif., Feb. 15, 2017 -- Praxsyn Corporation (OTCQB: PXYN) is pleased to announce that Praxsyn’s corporate headquarters have been moved from Irvine, California to Las Vegas, Nevada.

The board of directors authorized the move of Praxsyn Corporation’s headquarters to Nevada in order to allow for the expansion of Praxsyn’s operations, the ability to secure a larger pharmacy facility in Nevada at a more competitive price, and the overall lower labor costs.

Greg Sundem, PXYN’s Chief Executive Officer, stated “I have moved to Nevada from California because I believe it is important to be physically at any new facility to oversee the day-to-day operations and to ensure a successful transition.”

The new facility provides ample space for collection operations; with our increased focus on products and services that will pay within a 30-day billing cycle.  By changing the business model to a type of business that collects in a shorter amount of time, the company will have a more fiscally responsible financial model than the long collection cycle.

About Praxsyn Corporation

Headquartered in Las Vegas, Nevada, Praxsyn Corporation is a holding company that finds solutions to fit the needs and goals of medical professionals and their patients.  Mesa Pharmacy, located in Irvine, California works to realize the vision of medical professionals to improve the lives of their patients. Mesa Pharmacy continues its operations and services in Irvine, California to provide patients with pharmaceutical treatments as prescribed by their doctors.  Additional company information can be found at www.praxsyn.com.

Forward-Looking Statements

Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to statements in this press release regarding Praxsyn Corporation’s move to Las Vegas, Nevada, accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports as have been filed with the Securities and Exchange Commission.

 

                                                                             ###

Mesa Pharmacy Commences New Line of Business

FOR IMMEDIATE RELEASE


Media/Investor Contact:  

IR@praxsyn.com

949-777-6112 ext 101

IRVINE, Calif., Aug. 03, 2016 – Praxsyn Corporation (OTCQB:PXYN) is pleased to announce that its wholly owned subsidiary Mesa Pharmacy has begun accepting prescriptions for personal injury patients.

This new area of business is part of Mesa Pharmacy’s overall growth strategy to expand into new markets and new geographical locations.  Mesa Pharmacy is continuing to build sales on a national level and reach beyond the workers compensation space.

Greg Sundem, the company’s Chief Executive Officer stated, “Patients need easy access to prescription medications when they have been injured, and we intend on filling that gap when there is such a need. Our goal is to build a solid foundation, shipping to several states, accepting different types of cases, and holding more of the accounts receivable that are generated by the new line of business to provide an overall higher profit margin."

Personal injury cases are an exciting expansion for Mesa Pharmacy, it is estimated that there are over 300,000 injury automobile accident cases in California alone, and over 3,000,000 nationally. With over 30 million injury cases across the United States each year, including automobile accident injuries, slip and fall injuries, and work related injuries, Mesa Pharmacy is looking to provide quality pharmacy services for those injured patients.

About Praxsyn Corporation
Headquartered in Irvine, California, Praxsyn works to realize the vision of medical professionals to improve the lives of patients. Mesa Pharmacy, a wholly owned subsidiary, provides doctors with an alternative to oral pain medications. Mesa focuses on providing custom compounded non-narcotic, transdermal topical pain medications that are marketed to industrial health physicians and medical clinics. Mesa has developed a series of topical creams, in different strengths, that provide the pain relief doctors seek for their patients. Additional company information can be found at www.praxsyn.com.

Forward-Looking Statements
Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to statements in this press release regarding Mesa Pharmacy’s new line of business, accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports we filed with the SEC.

###

Update to Letter to Praxsyn Corporation’s Shareholders from its Chairman and CEO

FOR IMMEDIATE RELEASE

Media/Investor Contact:  

IR@Praxsyn.com

949-777-6112 ext 101

IRVINE, Calif., June 21, 2016 -- Praxsyn Corporation (OTC:PXYN) published a letter on April 15, 2016 to its shareholders from Greg Sundem, its Chairman and Chief Executive Officer.  This letter is from Mr. Sundem to update the Company’s shareholders as to the Company’s business and operations as of this date. 

Dear Shareholders,

I wanted to take an opportunity to update you as to our delay in filing our Annual Report on Form 10-K for the Fiscal Year ended December 31, 2015, and our Quarterly Report on Form 10-Q for the Quarter ended March 31, 2016.  Regrettably, we are delayed in our filings due to being in the final phase of our business reorganization and restructure of our operations.  I anticipate that the strong measures that I have instituted will have an overall positive effect on the Company. 

To that end, since my last letter to the shareholders, we have:

  • Commenced taking new prescriptions that do not require any upfront marketing costs, allowing us to greatly reduce the front end cost of new receivables.
  • I, together with our CFO/COO, and General Counsel/Secretary have deferred salaries until the Company’s overall cash flow has improved, however, as the rate of collections on our existing accounts receivable is rapidly increasing, this deferral is projected to end within the next few payroll cycles.
  • Commenced negotiations to restructure our long term debt.
  • Commenced the planning of establishing our first pharmacy outside the state of California.

In the next few weeks, we plan to

  • Publish our Form 10-K for the Fiscal Year ended December 31, 2015, and shortly thereafter publish our Form 10-Q for the Quarter ended March 31, 2016.
  • Commence our California sales of workers’ compensation cases that are pre-approved.
  • Commence auxiliary sales into out of state markets with what we believe will have substantially faster payment on claims.

In order to further increase our shareholder value, we are still planning to:

  • Acquire or become an FDA approved and fully licensed drug manufacturing facility so that we may offer products that we may sell to other pharmacies, hospitals and clinics.
  • Pursue accretive acquisitions of laboratories, and other medical providers who enjoy rapid claims payments.
  • Further diversify into additional medical industry profit centers.

Finally, we plan to vastly improve communications with our shareholders. To this end we plan to:

  • Frequently release company news through press releases.
  • Hold investor teleconferences or comprehensive press releases along with the release of each subsequent Annual and Quarterly filing.
  • Hire a staff member only dedicated to Investor Relations.

About Praxsyn Corporation
Headquartered in Irvine, California, Praxsyn works to realize the vision of medical professionals to improve the lives of patients. Mesa Pharmacy, a wholly owned subsidiary, provides doctors along with traditional medical treatments, with an alternative to oral pain medications. Mesa focuses on providing custom compounded non-narcotic, transdermal topical pain medications that are marketed to industrial health physicians and medical clinics. Mesa has developed a series of topical creams, in different strengths, that provide the pain relief doctors seek for their patients. Additional company information can be found at www.praxsyn.com.

Forward-Looking Statements
Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to statements regarding the past and future performance, past and future operations, expected cash on hand and anticipated results of the Company, accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports we filed with the SEC.

###

Letter to Praxsyn Corporation’s Shareholders from its Chairman and CEO

FOR IMMEDIATE RELEASE

Media/Investor Contact:  

IR@Praxsyn.com

949-777-6112 ext 101

IRVINE, Calif., April 15, 2016 -- Praxsyn Corporation (OTCQB:PXYN) announces today it will publish a Letter to its shareholders from its Chairman and CEO regarding the company’s business and operations.

Dear Shareholders,

On March 31, 2016, I accepted the position as the Chairman of the Board of Directors and Chief Executive Officer. Unfortunately, due to many factors, the company’s Annual Report on Form 10-K for the Fiscal Year ending December 31, 2015, which was due on that same date, will not be filed in a timely manner.  We took the available 15 day extension, however even with the extension, we will still need additional time to complete our Annual Report.

During 2015, we generated a substantial working capital deficit. We are delaying the filing of our Form 10-K in order to finish reorganizing our operations in order to dramatically reduce our deficit.  Prior to the release of the Annual Report, we have or will have:

  • Negotiated settlements with our vendors to reduce our marketing related debt by at least $5,000,000;
  • Reduced inefficiencies in executive staff in order to massively reduce overhead, cutting more than $500,000 in annual payroll, and currently myself, our CFO/COO and our General Counsel/Secretary are deferring salaries until the company’s overall cash flow is improved; and
  • Written down certain other assets, in order to eliminate any 2015 income tax liability.
     

However, to ensure that this situation will not repeated, we will no longer process workers’ compensation related prescriptions unless our costs are fully funded prior to the date of service.

In order to further increase our shareholder value, we plan in the future to:

  • Expand our sales efforts more fully into private insurance markets where payment is pre-approved by insurance carriers;
  • Pursue workers’ compensation cases that are already pre-approved;
  • Enter into negotiations with insurance carriers in order to dramatically reduce reimbursement rates, thereby ensuring prompt payment of all claims. If successful, we will reduce the cost of care for our patients, their insurers and ultimately their employers as well;
  • Become fully licensed in all 50 states as soon as practicable;
  • Expeditiously eliminate our long term debt;
  • Contract with marketing groups in other states to more fully diversify our product lines and markets;
  • Acquire an FDA approved and fully licensed drug manufacturing facility so that we may offer patients pain management creams (and other products) at massively reduced prices, under single NDC numbers, so that we sell to other pharmacies, hospitals and clinics;
  • Pursue accretive acquisitions of laboratories, and other medical providers who enjoy rapid claims payments; and
  • Further diversify into additional medical industry profit centers.
     

Finally, we plan to vastly improve communications with our shareholders. To this end we plan to:

  • Frequently release company news through regular press releases;
  • Hold investor teleconferences with the release of each subsequent annual and quarterly filing; and
  • Hire dedicated Investor Relations staff.
     

The last two years have seen many great strides and many setbacks for the Company and its shareholders, however, current management intends to bring a renewed focus on increasing shareholder value.

About Praxsyn Corporation
Headquartered in Irvine, California, Praxsyn works to realize the vision of medical professionals to improve the lives of patients. Mesa Pharmacy, a wholly owned subsidiary, provides doctors with an alternative to oral pain medications. Mesa focuses on providing custom compounded non-narcotic, transdermal topical pain medications that are marketed to industrial health physicians and medical clinics. Mesa has developed a series of topical creams, in different strengths, that provide the pain relief doctors seek for their patients. Additional company information can be found at www.praxsyn.com.

Forward-Looking Statements
Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to statements regarding the past and future performance, past and future operations, expected cash on hand and anticipated results of announcement of Praxsyn's new Chief Executive Officer and Chairman of the Board and, accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports we filed with the SEC.

###

Praxsyn Settles 79 Million Dollar Lawsuit, Appoints New CEO and COO

FOR IMMEDIATE RELEASE

Media/Investor Contact:  

IR@Praxsyn.com

949-777-6112 ext 101

IRVINE, Calif., April 11, 2016 -- Praxsyn Corporation (OTCQB:PXYN) is pleased to announce that it has settled its case against Trestles Pain Specialists, LLC and others (“TPS”) and TPS, has settled its case against Praxsyn and others. Both cases were settled with prejudice, meaning they cannot be brought again for litigation. In addition, due to the settlement, no party to the litigation will owe anything from the other and each is responsible for their own costs.

In other news, Praxsyn’s Board of Directors appointed Greg Sundem, 52, as its new Chief Executive Officer and added him to its Board of Directors as the Chairman of the Board. Justin Cary, the company’s CFO, was also appointed to the Board of Directors and as it’s Chief Operating Officer.

Mr. Sundem stated, “I am looking forward to expanding our product lines within Mesa Pharmacy and adding additional medical products and services within Praxsyn Corporation over the remainder of the year. We plan to greatly increase sales of pre-approved prescriptions in both the workers’ compensation and private insurance markets.”

“While we don’t plan a complete reboot of Praxsyn’s core products and services,” Mr. Sundem continued. “We are considering the acquisition of an FDA licensed manufacturing facility to enable us to expand our product offerings to include FDA licensed pain management creams.”

About Praxsyn Corporation
Headquartered in Irvine, California, Praxsyn works to realize the vision of medical professionals to improve the lives of patients. Mesa Pharmacy, a wholly owned subsidiary, provides doctors with an alternative to oral pain medications. Mesa focuses on providing custom compounded non-narcotic, transdermal topical pain medications that are marketed to industrial health physicians and medical clinics. Mesa has developed a series of topical creams, in different strengths, that provide the pain relief doctors seek for their patients. Additional company information can be found at www.praxsyn.com.

Forward-Looking Statements
Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to statements regarding the past and future performance, past and future operations, expected cash on hand and anticipated results of announcement of Praxsyn's new Chief Executive Officer and Chief Operating Officer and, accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports we filed with the SEC.

 

James Bradford Appointed to Praxsyn Corporation Board of Directors

FOR IMMEDIATE RELEASE


Media/Investor Contact:  

IR@praxsyn.com

949-777-6112 ext 101

IRVINE, Calif., Dec. 21, 2015 – Praxsyn Corporation (OTCQB:PXYN), a diversified holding company that finds alternative solutions to fit the needs and goals of their strategic relationships, announced that it has appointed James Bradford to its Board of Directors. Bradford also sits on the Board of Products for Doctors, Inc.

“James is an excellent addition to our Board as his experience and leadership in sales, finance and equities will be invaluable,” said Edward Kurtz, CEO of Praxsyn. “We look forward to tapping his expertise in building best practices within our organization.”

Mr. Bradford is an executive partner and founder of Products for Doctors, Inc. Prior to founding Products for Doctors, he was the president and founder of TK Carsites.  Bradford’s in-depth investment experience in commodities trading and private equity was garnered through his positions as an investment strategist at Manufacturers Asset Group, a regional sales manager at John James Investment, and a national sales manager at Hampton Group.

Bradford’s extensive experience includes sales management, marketing, software and service in B2B markets; product and channel development; cultivation of partnerships; acquisitions and private equity fund raising. He has held series 3 and 63 financial securities licenses, traded on the CBOT/CME and Forex, and specialized in trading securities, bonds and currencies.

About Praxsyn Corporation and Subsidiaries
Headquartered in Irvine, California, Praxsyn is a holding company who finds alternative solutions that prioritize the needs and goals of their strategic relationships. Mesa Pharmacy Inc., is a wholly owned subsidiary and a community retail pharmacy who provides custom medications that are marketed to health physicians and medical clinics. NexGen Med Solutions LLC is a wholly owned subsidiary who specializes in the billing and collections of worker’s compensation claims. Additional company information can be found at www.praxsyn.com.

Forward-Looking Statements
Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) and are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports we filed with the SEC.

###

PRAXSYN CORPORATION LAUNCHES NEW WEBSITE

FOR IMMEDIATE RELEASE


Media/Investor Contact:  

IR@PraXsyn.com

949-777-6112 ext 101

IRVINE, Calif., September 22, 2015 – Praxsyn Corporation (OTCQB: PXYN), a diversified holding company that finds alternative solutions to fit the needs and goals of their strategic relationships, is pleased to announce the launch of its new website www.praxsyn.com. According to Edward Kurtz, CEO of Praxsyn, the new website is aimed at highlighting the company’s strategic vision for growth and expansion over the next few years, and beyond.

“Our goal in launching this new website is to provide another resource for our partners and shareholders to learn more about Praxsyn,” said Edward Kurtz, CEO. “By redesigning the website to highlight Praxsyn’s key mission and goals, we hope to show our community of shareholders exactly who Praxsyn is, where we came from, and how we plan to continually expand.”

The new website offers a clean, modern design with easy to navigate functionality. Whether accessed from desktops, tablets or phones, the site features fully responsive design with a search engine that provides browsing capabilities. The investor relations page allows the public to easily access SEC filings that contain the company’s financials, as well as, the latest press releases, corporate governance information, and an updated list of Praxsyn’s noteworthy highlights. The site also provides social media integration and the ability to sign up for Praxyn’s newsletter, which is anticipated to feature regular updates on the company.

“We are focused on improving shareholder value and confidence through actively seeking fresh and creative ways in which to update our investors on Praxsyn’s newsworthy events,” said Lauren Doell, IR Manager. “

 About Praxsyn Corporation and Subsidiaries

Headquartered in Irvine, California, Praxsyn is a holding company who finds alternative solutions that prioritize the needs and goals of their strategic relationships. Mesa Pharmacy Inc., is a wholly owned subsidiary and a community retail pharmacy who provides custom medications that are marketed to health physicians and medical clinics. NexGen Med Solutions LLC is a wholly owned subsidiary who specializes in the billing and collections of worker’s compensation claims. Additional company information can be found at www.praxsyn.com.

Forward-Looking Statements


Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to statements regarding the company’s new website launch, and, accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports we filed with the SEC at http://www.sec.gov/.

 

###